Age, Comorbidity and Hypertensive Co-Medication do Not Affect Cardiovascular Tolerability of 10 Mg Alfuzosin Once Daily-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Age, Comorbidity and Hypertensive Co-Medication do Not Affect Cardiovascular Tolerability of 10 Mg Alfuzosin Once Daily

Published:2006-02 Issue:2 Volume:175 Page:624-628
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Hartung R.¹,Matzkin H.²,Alcaraz A.³,Emberton M.⁴,Harving N.⁵,van Moorselaar J.⁶,Elhilali M.⁷,Vallancien G.⁸,

Affiliation:

1. Department of Urology, Technische Universitat Munchen, Munich, Germany

2. Tel Aviv Sourasky Medical Center, Tel Aviv, Israel

3. Fundatio Puigvert, Barcelona, Spain

4. Middlesex Hospital, London, United Kingdom

5. Aalborg Sygehus, Aalborg, Denmark

6. University Medical Center Utrecht, Utrecht, The Netherlands

7. McGill University, Montreal, Quebec, Canada

8. Institut Mutualiste Montsouris, Paris, France

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference15 articles.

1. American Urological Association guideline on management of benign prostatic hyperplasia (2003). Chapter 1: diagnosis and treatment recommendations;J Urol,2003

2. α1-Adrenergic receptors and their inhibitors in lower urinary tract symptoms and benign prostatic hyperplasia;Roehrborn;J Urol,2004

3. Uroselective alpha-blockade for benign prostatic hyperplasia;Kaplan;Urology,1999

4. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone;JAMA,2000

5. Efficacy and safety of a new prolonged release formulation of alfuzosin 10 mg once daily versus alfuzosin 2.5 mg thrice daily and placebo in patients with symptomatic benign prostatic hyperplasia;van Kerrebroeck;Eur Urol,2000

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alfuzosin for the medical treatment of benign prostatic hyperplasia and lower urinary tract symptoms: a systematic review of the literature and narrative synthesis;Therapeutic Advances in Urology;2021-01

2. Alpha-bloquants et anticholinergiques chez le sujet âgé : comment prescrire ?;Progrès en Urologie - FMC;2015-03

3. Treatment with a Uroselective α1‐Blocker Improves Voiding and Sexual Function: A Study in Thai Men with Lower Urinary Tract Symptoms;The Journal of Sexual Medicine;2011-09

4. Sexuality and Management of Benign Prostatic Hyperplasia with Alfuzosin: SAMBA Thailand;The Journal of Sexual Medicine;2010-09

5. Medical therapy options for aging men with benign prostatic hyperplasia: focus on alfuzosin 10 mg once daily;Clinical Interventions in Aging;2008-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3